Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Molecular mechanisms of breast cancer tumours

Bookmark and Share

SABCS 2008

10 - 14 Dec 2008
Published: 12 Jan 2009
Views: 16394
Rating:
Save
Dr. Kornelia Polyak, Dana-Farber Cancer Institute
Investigating breast cancer tumour evolution and therapeutic resistance

Related Videos

Breast cancer in elderly patients: a clinicopathological review of a Nigerian...
Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀...
Breast cancer in elderly patients: a clinicopathological review of a Nigerian database ( Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀, Nigeria )
15 Dec 2022
Addition of platinum to standard neoadjuvant chemotherapy improves EFS in...
Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India
Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC ( Dr Sudeep Gupta - Tata Memorial Centre, Mumbai, India )
12 Dec 2022
Treatment decision guided by CTC count may improve long-term outcomes for mBC
Prof Jean-Yves Pierga - Institut Curie, Paris, France
Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )
9 Dec 2022
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Sep 2022
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine...
Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht...
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )
11 Sep 2022
Latest updates in treatment for the field of HER2-positive breast cancer
Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA
Latest updates in treatment for the field of HER2-positive breast cancer ( Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA )
8 Jul 2022
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast...
Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients ( Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA )
5 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation